Don McCormick, MD
Physical Medicine & Rehabilitation · Birmingham, ALNPI 1811309255
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (39.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 60.7% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2023 at $7,713 and has fallen 54.4% since, to $3,516 in 2025. Among physical medicine & rehabilitation clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 314 payments — averaging $70.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$14K
- Relievant Medsystems, Inc.$3K
- Vertos Medical, Inc.$2K
- Boston Scientific$682
- SPR Therapeutics, Inc$646
- Forte Bio-pharma LLC$552
- plus $1K from 21 others
What the payments were for
- Speaking & faculty fees$8,71539%
- Travel & lodging$5,36324%
- Food & beverage$8,18137%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 116 | $13,511 |
| Relievant Medsystems, Inc. | 28 | $3,222 |
| Vertos Medical, Inc. | 44 | $2,167 |
| Boston Scientific | 26 | $682 |
| SPR Therapeutics, Inc | 4 | $646 |
| Forte Bio-pharma LLC | 18 | $552 |
| Collegium Pharmaceutical, Inc. | 17 | $260 |
| Nevro Corp. | 3 | $242 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $180 |
| Almatica Pharma LLC | 7 | $152 |
| Amgen(2 entities) | 8 | $135 |
| MML US, Inc. | 3 | $80 |
| Azurity Pharmaceuticals, Inc. | 4 | $62 |
| Arbor Pharmaceuticals, Inc. | 4 | $55 |
| Biodelivery Sciences International, Inc. | 3 | $43 |
| IBSA Pharma Inc. | 2 | $41 |
| Pfizer | 3 | $38 |
| Vertex | 2 | $38 |
| Globus Medical | 1 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $24 |
| Redhill Biopharma Inc. | 1 | $18 |
| GRT US Holding, Inc. | 1 | $17 |
| Baudax Bio Inc. | 1 | $16 |
| Scilex Pharmaceuticals Inc. | 1 | $13 |
| Stimwave Technologies Incorporated | 1 | $13 |
| Assertio Therapeutics, Inc. | 1 | $12 |
| Si-bone, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$9,401
- Intracept$4,230
- VANTA ADAPTIVESTIM$1,961
- mild Device Kit$1,258
- Prolate$960
- SPRINT PNS System$601
- INTELLIS$260
- Nalocet$240
- Omnia$227
- INCEPTIV$100
How this compares
$22,259 in reported general payments places this provider in the 95th percentile of 104 physical medicine & rehabilitation providers in Alabama.
See all physical medicine & rehabilitation providers in Alabama →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 260 | $55,311 |
| BelbucaBuprenorphine Hcl | 62 | $52,304 |
| Xtampza ErOxycodone Myristate | 121 | $49,726 |
| NalocetOxycodone Hcl/Acetaminophen | 16 | $24,812 |
| Nucynta ErTapentadol Hcl | 25 | $22,152 |
| Tramadol Hcl ErTramadol Hcl | 152 | $9,420 |
| Gabapentin | 929 | $8,770 |
| Hydrocodone Bitartrate ErHydrocodone Bitartrate | 18 | $6,252 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 563 | $4,240 |
| Diclofenac Sodium | 321 | $4,028 |
| Pregabalin | 99 | $3,578 |
| NucyntaTapentadol Hcl | 12 | $3,544 |
| Morphine Sulfate ErMorphine Sulfate | 61 | $1,270 |
| Methocarbamol | 191 | $1,135 |
| Celecoxib | 82 | $1,005 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta Er, Nucynta | $260 | $127,726220 claims |
| Forte Bio-pharma LLCNalocet | $552 | $24,81216 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 104 physical medicine & rehabilitation providers in Alabama.
Other physical medicine & rehabilitation in Birmingham
- Bradly GoodmanBirmingham$15K
- Nelson Santos AgostoBirmingham$14K
- John PantuoscoBirmingham$12K
- Ross LumsdenBirmingham$11K
- Matthew BerkeBirmingham$6K
- Chong WengBirmingham$4K
- Kenneth SmithBirmingham$4K
- Srinivas MallempatiBirmingham$3K
- Aaron GreenbergBirmingham$3K
- Natalie DeanBirmingham$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.